- Home
- CRMD vs WIW Comparison
CRMD vs WIW Comparison
Compare CRMD & WIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- WIW
- Stock Information
- Founded
- CRMD 2006
- WIW 2004
- Country
- CRMD United States
- WIW United States
- Employees
- CRMD N/A
- WIW N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- WIW Finance Companies
- Sector
- CRMD Health Care
- WIW Finance
- Exchange
- CRMD Nasdaq
- WIW Nasdaq
- Market Cap
- CRMD 464.7M
- WIW 537.8M
- IPO Year
- CRMD 2010
- WIW N/A
- Fundamental
- Price
- CRMD $12.03
- WIW $8.58
- Analyst Decision
- CRMD Strong Buy
- WIW
- Analyst Count
- CRMD 6
- WIW 0
- Target Price
- CRMD $15.00
- WIW N/A
- AVG Volume (30 Days)
- CRMD 2.1M
- WIW 229.9K
- Earning Date
- CRMD 05-06-2025
- WIW 01-01-0001
- Dividend Yield
- CRMD N/A
- WIW 11.14%
- EPS Growth
- CRMD N/A
- WIW N/A
- EPS
- CRMD 0.28
- WIW N/A
- Revenue
- CRMD $82,553,827.00
- WIW N/A
- Revenue This Year
- CRMD $207.65
- WIW N/A
- Revenue Next Year
- CRMD $50.13
- WIW N/A
- P/E Ratio
- CRMD $43.34
- WIW N/A
- Revenue Growth
- CRMD N/A
- WIW N/A
- 52 Week Low
- CRMD $3.61
- WIW $8.01
- 52 Week High
- CRMD $13.85
- WIW $9.37
- Technical
- Relative Strength Index (RSI)
- CRMD 76.78
- WIW 47.91
- Support Level
- CRMD $8.72
- WIW $8.57
- Resistance Level
- CRMD $9.82
- WIW $8.65
- Average True Range (ATR)
- CRMD 0.65
- WIW 0.07
- MACD
- CRMD 0.42
- WIW 0.01
- Stochastic Oscillator
- CRMD 94.49
- WIW 50.00
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.